Federal Circuit decision involving Netlist and Micron shows why finding an error in a patent ruling may not be enough to overturn it. If another independent basis supports the same result, the error may be treated as harmless.
A Federal Circuit decision involving the cancer drug Cabometyx highlights an important distinction between obtaining a patent and having the right to commercialize an invention. A later patent on an improvement may still fall within the scope of an earlier, broader patent.
A Federal Circuit decision shows why challenging a government policy requires more than disagreement or advocacy costs. The plaintiff must show a concrete, ongoing injury before a court can reach the merits.
CAFC leaves the Range of Motion v. Armaid design patent framework intact, preserving judicial claim construction and the plainly dissimilar shortcut.
In Dental Monitoring v. Align, the Federal Circuit holds that AIA provisional prior art requires § 112(a) written-description support for a published claim.